Med Ed Report briefs: March 2014

Share this article:
Carmen Ortiz
Carmen Ortiz

Carmen Ortiz, US Attorney for the District of Massachusetts (pictured), said at the 2014 CBI Pharmaceutical Compliance Congress last month that her office and other government branches have “greater knowledge of the industry” and that more “specialized units and divisions” are being created to investigate and prosecute healthcare fraud, the blog Policy and Medicine reported.

Eli Lilly launched a four-week rotation program for aspiring ­physicians at its Indianapolis headquarters. Students from Tulane University School of Medicine will be the first to participate in the pilot program. The assignments cut across different aspects of the company's business—from drug discovery and development to bioethics and patient safety—and provide third- and fourth-year students “a lens into the industry, its vision and focus on improving patient outcomes,” Lilly said.

According to a post on the New York Times's Hard Cases blog, ­modern medical education may leave newly minted doctors fearful of missing a worst-case diagnosis and therefore too eager to order any expensive tests.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.